Greg Guyer
EVP and Chief Technical Officer at BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.•Flourtown, Pennsylvania, United States
View LinkedIn ProfileExperience34+ Years
LevelCXO
Executive Overview
Experienced Head Of Operations with a demonstrated history of delivering results and driving transformational change in the global biopharmaceuticals industry based in multiple geographies. Strong business and manufacturing operations professional skilled in Biologics and Small Molecules, global Regulatory, SAP implementation, global Quality, GMP, and Quality Assurance.
Career Timeline
- BioMarin Pharmaceutical Inc.CurrentMay 2020–Present· 6 yrs 6 mos
- Executive Vice President and Chief Technical OfficerCurrentMay 2020–Present
- Nov 2015–Nov 2019· 4 yrs
- Head, IT Operations, GlobalJul 2017–Nov 2019
- Global Head & Senior Vice President, Biologics Process Development and OperationsNov 2015–Jun 2017
- Sep 1994–Oct 2015· 21 yrs 1 mo
- Senior Vice President Operations, Biologics, Therapeutic Proteins and Sterile ProductsJul 2014–Oct 2015
- Senior Vice President, Global QualityJun 2010–Jul 2014
- VP, Emerging MarketsOct 2009–Jun 2010
- VP, SAPOct 2005–Oct 2009
- Vice President, Asia Pacific OperationsAug 2003–Oct 2005
- Vice President, Worldwide Quality Assurance2000–Sep 2003
- Sr. Director, North America Quality Operations1997–2000
- Sr. Director, Regulatory CMCSep 1994–1997
- Aug 1992–Sep 1994· 2 yrs 1 mo
- Director, Office of Generic DrugsAug 1992–Sep 1994
Education
Master of Business Administration - MBA
Marketing
Lehigh University College of BusinessDoctor of Philosophy - PhD
Analytical Chemistry
American UniversityBachelor of Science - BS
Chemistry
University of Georgia - Franklin College of Arts and SciencesExecutive Relationship Map
Reports To
Greg Guyer
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
Skills & Expertise
Change ManagementRegulatory AffairsSopTechnology TransferChange ControlNew Business Development21 CFR Part 11CAPABiopharmaceuticalsGMPFDAValidationU.S. Food and Drug Administration (FDA)Quality AssuranceVaccinesBusiness DevelopmentBPFPharmaceutical IndustryBiotechnology